Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver
NCT ID: NCT03151213
Last Updated: 2018-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
100 participants
INTERVENTIONAL
2017-05-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).
NCT05804591
Effect of Preoperative Oral Pregabalin Versus Intraoperative Fentanyl on Postoperative Analgesia
NCT05150795
Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery
NCT03714867
The Effects of Pregabalin on Postoperative Pain After Cardiac Surgery
NCT01701921
The Efficacy of Pregabalin on the Duration of the Spinal Anesthesia and the Early Postoperative Pain After Total Knee Arthroplasty
NCT05071118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregabalin
Pregabalin 150 mg before intervention
Pregabalin 150mg
Pregabalin 150mg before RFA of liver cancer
Placebo
Placebo before intervention
Placebo
Placebo before RFA of liver cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pregabalin 150mg
Pregabalin 150mg before RFA of liver cancer
Placebo
Placebo before RFA of liver cancer
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sherief Abd-Elsalam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
PhDTropical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amr Magdy Abdelfattah, consultant
Role: PRINCIPAL_INVESTIGATOR
Tanta University Faculty of Medicine
Sherief Abd-Elsalam, Consultant
Role: STUDY_DIRECTOR
Tanta university Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university - faculty of medicine
Cairo, Elgharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
amr magdy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.